MiniMed Raises $560 Million in US Initial Public Offering
MiniMed raised $560 million in its U.S. initial public offering on Thursday. The diabetes unit of Medtronic announced the pricing of the stock market debut.
Xurve View
Insights:
Xurve View
The diabetes-focused business unit of Medtronic plc, known as MiniMed, has successfully raised $560 million in its initial public offering within the United States. The announcement, made on Thursday, marks a significant milestone for the medical technology company as it seeks to provide its diabetes division with the financial independence necessary to accelerate innovation and market expansion.
